Effect of acetylethylcholine mustard on muscarinic receptor-coupled attenuation of cAMP formation in intact GH3 cells
- PMID: 2164088
Effect of acetylethylcholine mustard on muscarinic receptor-coupled attenuation of cAMP formation in intact GH3 cells
Abstract
The effects of acetylethylcholine mustard (Aech-M) on the muscarinic receptor coupled adenylate cyclase system of intact GH3 cells were investigated. The concentration of Aech-M and Ach that inhibited specific [3H]N-methylscopolamine binding by 50% was similar for both compounds (9.3 microM for Ach and 10.7 microM for Aech-M). Pretreatment of intact GH3 cells or isolated membranes with 10 to 50 microM Aech-M, followed by washing, reduced the [3H]N-methylscopolamine binding capacity by 60% and 75-77%, respectively, without changing the KD value for the radioligand to the remaining receptors. Both Aech-M and Ach attenuated forskolin (1 microM) stimulated cAMP formation with half-maximal effects (EC50) occurring at 0.84 microM for Ach and 0.24 microM for Aech-M. The maximal inhibition was 70-80% for Ach and 30-40% for Aech-M. However, the dose-response for Aech-M was biphasic such that at high concentrations (greater than 50 microM) there was a reduction in its ability to attenuate cAMP formation. After 3 min incubation with either Ach or Aech-M, the addition of atropine completely reversed their inhibitory effect even though with Aech-M there was a greater than 50% reduction in receptor capacity. Furthermore, over a 12-min incubation, Ach produced a relatively stable 67-76% reduction in cAMP accumulation, whereas with Aech-M the initial attenuation was gradually reduced such that by 10 min of incubation, no effect was observed. Finally, pretreatment with Aech-M resulted in a reduced sensitivity to the action of Ach as the EC50 values for inhibition of cAMP accumulation were increased 7.6- and 13.5-fold, respectively, with little or no change in the maximal response. The data indicate that Aech-M produces a transient agonist effect to attenuate cAMP formation in intact GH3 cells followed by an antagonist action probably after irreversible binding to the receptor.
Similar articles
-
Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.Mol Pharmacol. 1986 Nov;30(5):411-8. Mol Pharmacol. 1986. PMID: 3773882
-
Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.Br J Pharmacol. 1997 Oct;122(3):401-8. doi: 10.1038/sj.bjp.0701357. Br J Pharmacol. 1997. PMID: 9351494 Free PMC article.
-
Dissociation between muscarinic receptor-mediated inhibition of adenylate cyclase and autoreceptor inhibition of [3H] acetylcholine release in rat hippocampus.J Pharmacol Exp Ther. 1989 Dec;251(3):1039-44. J Pharmacol Exp Ther. 1989. PMID: 2557410
-
Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.Br J Pharmacol. 1998 May;124(1):47-54. doi: 10.1038/sj.bjp.0701792. Br J Pharmacol. 1998. PMID: 9630342 Free PMC article.
-
An agonist that is selective for adenylate cyclase-coupled muscarinic receptors.Mol Pharmacol. 1989 Sep;36(3):465-70. Mol Pharmacol. 1989. PMID: 2550780
Cited by
-
Sigma binding in a human neuroblastoma cell line.Neurochem Res. 1996 Nov;21(11):1309-14. doi: 10.1007/BF02532372. Neurochem Res. 1996. PMID: 8947921